Log on / register
Feedback | Support | My details

Comments

Systemic zoledronate treatment both prevents resorption of allograft bone and increases the retention of new formed bone during revascularization and remodelling. A bone chamber study in rats

Jörgen Åstrand email, Anna Kajsa Harding email, Per Aspenberg email and Magnus Tägil email

BMC Musculoskeletal Disorders 2006, 7:63doi:10.1186/1471-2474-7-63

No comments have yet been made on this article

Post a comment

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.